Navigation Links
Accera Announces Initiation of Clinical Trial for AC-1204
Date:11/26/2012

BROOMFIELD, Colo., Nov. 26, 2012 /PRNewswire/ -- Accera, Inc., a privately-held, commercial-stage, healthcare company focused on the discovery and development of innovative clinical applications to address acute and chronic neurodegenerative diseases, announced today the initiation of a clinical efficacy trial examining the effects of AC-1204 in patients with mild-to-moderate Alzheimer's disease (AD).  AC-1204 is a formulation of caprylic triglyceride designed to improve cognitive function in mild to moderate Alzheimer's disease.

The study, (Titled: NOURISH AD), "A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Subjects with Mild to Moderate Alzheimer's Disease (AD) with an Optional 26 Week Open-Label Extension," will examine the efficacy of 26 weeks daily administration of AC-1204 compared with placebo among participants diagnosed with mild-to-moderate AD. 

"With the recent investment we received from Nestlé Health Science, we're eager to generate additional clinical data illustrating the effectiveness of our product in patients with mild-to-moderate Alzheimer's disease," said Holger Kunze, president and CEO of Accera.  "We believe we have a truly innovative approach that will meet the needs of patients in this overwhelmingly underserved market." 

Accera's technology addresses the well-recognized physiological hallmark of the brain's inability to optimally metabolize glucose by providing an alternative energy source for brain cells.  In previous clinical trials, this approach has been shown to safely improve memory and cognitive function by inducing safe, therapeutic, tolerable and predictable levels of ketosis that improves memory in patients with mild-to-moderate AD.

The study will be a randomized, double-blind, placebo-controlled, parallel-group, multi-center trial.  It will be conducted at approx
'/>"/>

SOURCE Accera, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... -- Lakeland Industries, Inc. (NASDAQ: LAKE ), a ... and to first responders on the federal, state and ... fiscal 2013 fourth quarter and year ended January 31, ... close and will conduct a conference call on the ... http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) The call will ...
(Date:5/17/2013)... May 17, 2013  Sony Biotechnology Inc. ("Sony") today announced ... holder and 130um sorting chip.  Sony will also be exhibiting ... new SH800 Cell Sorter, the EC800 flow cytometer, and new ... CYTO 2013, which will be held at the ... Diego, California , from May 20 - 22.  ...
(Date:5/17/2013)... , May 17, 2013  ConvaTec today announced that it will ... Ken Berger , CEO, and Ed Borkowski ... ET live via telephone. To participate in the conference ... 366-0267. To participate in the conference call outside the U.S. ... The conference ID is 72195398. Participants should dial in 10 ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Sony Delivers New Technology for Science to CYTO 2013 2
... (Soligenix or the Company) (OTC Bulletin Board: ... its President and Chief Executive Officer Christopher J. Schaber, ... at the Rodman & Renshaw 12th Annual Healthcare Conference ... on Wednesday, September 15, 2010 at 10:00AM EDT in ...
... Calif., Sept. 10 Sutter Health today announced a donation ... Red Cross to aid in relief efforts following a destructive ... and shelter. The donation is made on behalf of the ... addition to $50,000 generously donated by Sutter-affiliated California Pacific Medical ...
Cached Medicine Technology:Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT 2Soligenix to Present at the Rodman & Renshaw Healthcare Conference on September 15, 2010 at 10AM EDT 3Sutter Health Network Donates $150,000 to Aid Victims of San Bruno Fire 2
(Date:5/18/2013)... 18 (HealthDay News) -- Just a few extra cups ... of an autoimmune liver disease known as primary sclerosing ... the Mayo Clinic in Rochester, Minn., found that drinking ... the disease, which can lead to cirrhosis of the ... does not prove a cause-and-effect relationship. "While ...
(Date:5/18/2013)... are significant cost and risk factors associated with ... gastrointestinal problems, according to research presented at Digestive ... New York Presbyterian Hospital and Weill-Cornell Medical College ... the cost and risk of managing gastroesophageal reflux ... nearly 25 percent of adults, researchers found that ...
(Date:5/18/2013)... May 18, 2013 Assisted living ... comes to safety and comfort of their residents. ... provides clients with an effective and cost-efficient solution ... is an integrated, turnkey communications solution that helps ... allowing residents independence and privacy. , The ...
(Date:5/18/2013)... York (PRWEB) May 18, 2013 ... mesh products continue to move forward in a consolidated ... Bernstein Liebhard LLP reports. According to a notice on ... the Ethicon pelvic mesh litigation will be held on ... complaints have been filed in the proceeding on behalf ...
(Date:5/18/2013)... May 18, 2013 The “World Healthcare ... and studies the major market drivers, restraints, and opportunities ... world. , Browse , 89 ... in-depth TOC on "Healthcare IT Market" , ... customization on reports. , The global healthcare IT market ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3
... the growing shift toward oral chemotherapy agents offers cancer patients ... of the new medications also poses more chances for patients ... in a dangerous way. An increasing number of cancer patients ... click of a pill bottle each day rather than the ...
... 28 Niutang Chemical , one ... in the world, today announced it plans to ... 300 metric tons, within the next three years. ... its sucralose capacity to 1,000 metric tons by 2014.(Logo: ...
... PerformLOS ANGELES, May 28 The Pediatric Inflammatory Bowel ... Producer Alexandra Milchan-Lambert and Relativity Media President of Production ... 2009 at Culver Studios. The afternoon will celebrate ... and will feature a fun-filled day of activities including ...
... WASHINGTON, May 28 The State of Florida took ... children yesterday when Governor Charlie Crist signed a $1 ... legislature through the budget dramatically increased funding for smoking ... toll-free QuitLine (877-U-CAN-NOW).Florida,s cigarette tax had been the fourth ...
... A new statewide poll of registered voters finds ... to give the U.S. Food and Drug Administration (FDA) the ... expected to debate this issue next week, and Senators Webb ... Congress will finally pass this life-saving legislation.(Logo: ...
... many potential new drug targets for cancers long deemed ... contain. These studies are beginning to reveal new ways ... of normal genes that cancer cells rely on for ... Medical Institute (HHMI) investigators D. Gary Gilliland of Brigham ...
Cached Medicine News:Health News:Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy 2Health News:Compliance and cost: Bitter pills to swallow in the age of oral chemotherapy 3Health News:Niutang to Expand Sucralose Capacity 66 Percent by 2012 2Health News:The Pediatric IBD Center at Cedars-Sinai Medical Center Presents Rock-n-Reel 2009 Honoring Alexandra Milchan-Lambert & Scott Lambert 2Health News:Florida's $1 Cigarette Tax Increase a Big Win for Public Health 2Health News:Florida's $1 Cigarette Tax Increase a Big Win for Public Health 3Health News:New Virginia Poll: 71 Percent of Voters Strongly Support FDA Regulation of Tobacco Products 2Health News:New Virginia Poll: 71 Percent of Voters Strongly Support FDA Regulation of Tobacco Products 3Health News:The vulnerable cancer cell 2Health News:The vulnerable cancer cell 3Health News:The vulnerable cancer cell 4Health News:The vulnerable cancer cell 5Health News:The vulnerable cancer cell 6
Toxo IgG ELISA. All Wampole ELISA kits include the following: 12 x 8 well strips with breakaway wells, sample diluent, controls and calibrators, conjugate, TMB substrate, wash buffer, stop solution,...
Herpes Simplex Virus 2 IgG ELISA....
Blunt tipped forceps with tungsten carbide treated jaws for enhanced gripping and removal of large sized foreign bodies....
Blunt tipped forceps with entire interior surface of tip serrated. For general purpose membrane grasping (coarse membranes)....
Medicine Products: